Ranganath Anil P. 4
4 · TransMedics Group, Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Ranganath Anil P.
See remarks
Transactions
- Exercise/Conversion
Common Stock
2025-11-25$93.88/sh+3,000$281,640→ 16,955 total - Sale
Common Stock
2025-11-25$145.22/sh−3,000$435,660→ 13,955 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−3,000→ 7,420 totalExercise: $93.88Exp: 2033-08-01→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $145.00 to $145.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The option vested as to 25% on June 5, 2024 and will vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.